miRNA-Based Technologies in Cancer Therapy
Journal of Personalized Medicine · 09.11.2023 · 13 (11) · 1586
DOI: 10.3390/jpm13111586 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Personalized Medicine, online erschienen am 09.11.2023. Verfasst von Maria Pagoni und 6 weiteren Autor:innen. Beteiligte Einrichtung: Research Group of Clinical Pharmacology and Pharmacogenomics, Faculty of Pharmacy, School of Health Sciences, National and Kapodistrian University of…. Die Arbeit wurde bisher 88-mal zitiert (Crossref) und nennt 309 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The discovery of therapeutic miRNAs is one of the most exciting challenges for pharmaceutical companies. Since the first miRNA was discovered in 1993, our knowledge of miRNA biology has grown considerably. Many studies have demonstrated that miRNA expression is dysregulated in many diseases, making them appealing tools for novel therapeutic approaches. This review aims to discuss miRNA biogenesis and function, as well as highlight strategies for delivering miRNA agents, presenting viral, non-viral, and exosomic delivery as therapeutic approaches for different cancer types. We also consider the therapeutic role of microRNA-mediated drug repurposing in cancer therapy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Research Group of Clinical Pharmacology and Pharmacogenomics, Faculty of Pharmacy, School of Health Sciences, National and Kapodistrian University of Athens, 15701 Athens, Greece.
- Department of Science, Technology and Society, University School for Advanced Studies IUSS Pavia, 27100 Pavia, Italy.
- Department of Biochemistry and Molecular Biology, Faculty of Biology, National and Kapodistrian University of Athens, 15701 Athens, Greece.
- Laboratory of Clinical Biochemistry-Molecular Diagnostics, Second Department of Pediatrics, School of Medicine, "P. & A. Kyriakou" Children's Hospital, National and Kapodistrian University of Athens, 11527 Athens, Greec…
- Biomedical Applications Unit, Institute of Chemical Biology, National Hellenic Research Foundation (NHRF), 11635 Athens, Greece.
- Centre of Systems Biology, Biomedical Research Foundation, Academy of Athens, 11527 Athens, Greece.
ORCID-Profile: Maria Pagoni, Claudia Cava, Margaritis Avgeris, Ioannis Michalopoulos, Nikolaos Drakoulis
Zitieren
APA
Pagoni, M., Cava, C., Sideris, D. C., Avgeris, M., Zoumpourlis, V., Michalopoulos, I., & Drakoulis, N. (2023). miRNA-Based Technologies in Cancer Therapy. Journal of Personalized Medicine, 13(11), 1586. https://doi.org/10.3390/jpm13111586
Vancouver
Pagoni M, Cava C, Sideris DC, Avgeris M, Zoumpourlis V, Michalopoulos I, et al. miRNA-Based Technologies in Cancer Therapy. Journal of Personalized Medicine. 2023;13(11):1586. doi:10.3390/jpm13111586
BibTeX
@article{Pagoni2023,
author = {Pagoni, Maria and Cava, Claudia and Sideris, Diamantis C and Avgeris, Margaritis and Zoumpourlis, Vassilios and Michalopoulos, Ioannis and Drakoulis, Nikolaos},
title = {miRNA-Based Technologies in Cancer Therapy},
journal = {Journal of Personalized Medicine},
year = {2023},
volume = {13},
number = {11},
pages = {1586},
doi = {10.3390/jpm13111586}
}
EUVIMED